The Calmer Co. International (ASX:CCO), a health and wellness company, has announced significant board and management changes. John Homewood, the largest individual shareholder, will join as Non-Executive Chairman. Anthony Noble will transition to a non-executive role by March 2025, and company founder Zane Yoshida will become CEO. These changes are part of a strategic shift to enhance focus on sales, particularly in the US and Australian markets.
The Calmer Co. International (ASX:CCO) is undergoing a strategic restructuring of its board and management to enhance its sales focus and market expansion, particularly in the US and Australia. John Homewood has been appointed as Non-Executive Chairman, with Anthony Noble moving to a non-executive role and Zane Yoshida assuming the CEO position. The restructuring includes withdrawing certain AGM resolutions and aims to create a leaner, more sales-driven organization tailored for growth. The company plans to increase its retail footprint, enhance operational efficiency, and drive towards breakeven. With the completion of quality assurance and factory upgrades, The Calmer Co. is positioned to capitalize on growth opportunities within the health and wellness sector.
Anthony Noble emphasizes the focus on shareholder value and strategic fit of the board and management. Zane Yoshida expresses confidence in John Homewood’s leadership and views on growth and future milestones. John Homewood looks forward to contributing to the company's growth based on his extensive business experience.